Clinical implications of the 2021 edition of the WHO classification of central nervous system tumours

C Horbinski, T Berger, RJ Packer, PY Wen - Nature Reviews Neurology, 2022 - nature.com
A new edition of the WHO classification of tumours of the CNS was published in 2021.
Although the previous edition of this classification was published just 5 years earlier, in …

Brain borders at the central stage of neuroimmunology

J Rustenhoven, J Kipnis - Nature, 2022 - nature.com
The concept of immune privilege suggests that the central nervous system is isolated from
the immune system. However, recent studies have highlighted the borders of the central …

Molecular classification to refine surgical and radiotherapeutic decision-making in meningioma

JZ Wang, V Patil, AP Landry, C Gui, A Ajisebutu, J Liu… - Nature medicine, 2024 - nature.com
Abstract Treatment of the tumor and dural margin with surgery and sometimes radiation are
cornerstones of therapy for meningioma. Molecular classifications have provided insights …

Detection of diagnostic and prognostic methylation-based signatures in liquid biopsy specimens from patients with meningiomas

GA Herrgott, JM Snyder, R She, TM Malta… - Nature …, 2023 - nature.com
Recurrence of meningiomas is unpredictable by current invasive methods based on
surgically removed specimens. Identification of patients likely to recur using noninvasive …

Meningioma: International Consortium on Meningiomas consensus review on scientific advances and treatment paradigms for clinicians, researchers, and patients

JZ Wang, AP Landry, DR Raleigh, F Sahm… - Neuro …, 2024 - academic.oup.com
Meningiomas are the most common primary intracranial tumors in adults and are increasing
in incidence due to the aging population and increased access to neuroimaging. While most …

Super-enhancer hijacking drives ectopic expression of hedgehog pathway ligands in meningiomas

MW Youngblood, Z Erson-Omay, C Li, H Najem… - Nature …, 2023 - nature.com
Hedgehog signaling mediates embryologic development of the central nervous system and
other tissues and is frequently hijacked by neoplasia to facilitate uncontrolled cellular …

Meningeal lymphatics in central nervous system diseases

AFM Salvador, N Abduljawad… - Annual Review of …, 2024 - annualreviews.org
Since its recent discovery, the meningeal lymphatic system has reshaped our understanding
of central nervous system (CNS) fluid exchange, waste clearance, immune cell trafficking …

Hypermitotic meningiomas harbor DNA methylation subgroups with distinct biological and clinical features

A Choudhury, WC Chen, CHG Lucas… - Neuro …, 2023 - academic.oup.com
Background Meningiomas, the most common primary intracranial tumors, can be separated
into 3 DNA methylation groups with distinct biological drivers, clinical outcomes, and …

Loss of p16 expression is a sensitive marker of CDKN2A homozygous deletion in malignant meningiomas

V Tang, R Lu, K Mirchia, J Van Ziffle, P Devine… - Acta …, 2023 - Springer
While meningiomas are generally benign, slow-growing tumors with excellent post-surgical
outcomes, a significant subset follows a more aggressive clinical course resistant to existing …

Perivascular NOTCH3+ Stem Cells Drive Meningioma Tumorigenesis and Resistance to Radiotherapy

A Choudhury, MA Cady, CHG Lucas, H Najem… - Cancer …, 2024 - aacrjournals.org
Meningiomas are the most common primary intracranial tumors. Treatments for patients with
meningiomas are limited to surgery and radiotherapy, and systemic therapies remain …